Methods for treating refractory hypercholesterolemia involving an angptl3 inhibitor
Номер патента: EP4192446A1
Опубликовано: 14-06-2023
Автор(ы): Daniel A. SCHWEMMER GIPE (Deceased), Robert C. PORDY, Shazia ALI
Принадлежит: Regeneron Pharmaceuticals Inc
Опубликовано: 14-06-2023
Автор(ы): Daniel A. SCHWEMMER GIPE (Deceased), Robert C. PORDY, Shazia ALI
Принадлежит: Regeneron Pharmaceuticals Inc
Реферат: The present invention provides methods for treating patients suffering from refractory hypercholesterolemia. The methods of the invention provide for lowering at least one lipid parameter in the patient by administering a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to ANGPTL3 in combination with a therapeutically effective amount of a statin, a first lipid lowering agent other than a statin, and a second lipid lowering agent other than a statin.
Methods for treating patients with refractory hypercholesterolemia
Номер патента: US20240197870A1. Автор: Robert C. PORDY,Daniel A. Schwemmer Gipe,Shazia ALI. Владелец: Regeneron Pharmaceuticals Inc. Дата публикации: 2024-06-20.